iddi presentation
TRANSCRIPT
![Page 1: IDDI Presentation](https://reader035.vdocument.in/reader035/viewer/2022062406/55be32c8bb61eb59658b4593/html5/thumbnails/1.jpg)
IDDI / Corporate Presentation eClinical and Biostatistical Services
![Page 2: IDDI Presentation](https://reader035.vdocument.in/reader035/viewer/2022062406/55be32c8bb61eb59658b4593/html5/thumbnails/2.jpg)
Company History
20111996 2001 2004 20061991
SARL, Paris
Operations centered in
Belgium
2010
Inc.
2010
Inc.
Houston, TX, USACambridge, MA, USA
![Page 3: IDDI Presentation](https://reader035.vdocument.in/reader035/viewer/2022062406/55be32c8bb61eb59658b4593/html5/thumbnails/3.jpg)
IDDI , a Clinical Data Center
The mission of IDDI is to deliver clinical trial results that are
scientifically accurate, validated and reproducible.
3
![Page 4: IDDI Presentation](https://reader035.vdocument.in/reader035/viewer/2022062406/55be32c8bb61eb59658b4593/html5/thumbnails/4.jpg)
Expertise
Consultancy
Clinical trial program strategy, protocol design, expert mission with regulatory agencies
Randomization and Drug Supply Management
(e)-CRF Design and Data ManagementBiostatistical Services
Biostatistical AnalysesMeta-analyses
Biomarkers QualificationIDMC supportMedical Writing
![Page 5: IDDI Presentation](https://reader035.vdocument.in/reader035/viewer/2022062406/55be32c8bb61eb59658b4593/html5/thumbnails/5.jpg)
Web systems
eClinical Suite
Central Randomization (ID-net™) and Treatment Allocation (ID-supply™)Data Management (EDC) integrated with ID-net™Coding of Medical Terms (ID-code™)
Secured sharing of documents and data (TrialControl™)Validation of systemsCustomer support
![Page 6: IDDI Presentation](https://reader035.vdocument.in/reader035/viewer/2022062406/55be32c8bb61eb59658b4593/html5/thumbnails/6.jpg)
Global Experience (> 2002)
500+ Phase I-IV trials160+ Randomization systems in
100+ countries 50,000+ patients 6,000+ sites
350+ Publications400+ Scientific presentations10 Scientific seminars since 20038 Webinars since 2010
6
![Page 7: IDDI Presentation](https://reader035.vdocument.in/reader035/viewer/2022062406/55be32c8bb61eb59658b4593/html5/thumbnails/7.jpg)
Client Base
+75% repeat business!
Academic Group17%
Biotechnology56%
Pharmaceu-tical24%
Other (Medical Devices, Nutri-tion…)
3%
Over the last 5 years IDDI worked with 110+ clients worldwide
Currently 75 clients – 180 projects
![Page 8: IDDI Presentation](https://reader035.vdocument.in/reader035/viewer/2022062406/55be32c8bb61eb59658b4593/html5/thumbnails/8.jpg)
FDA / EMA approvals
Involvement in
15
FDA/EMA approvals
and currently working on 30+ studies to be used in submission dossiers in the US and/or Europe
8
![Page 9: IDDI Presentation](https://reader035.vdocument.in/reader035/viewer/2022062406/55be32c8bb61eb59658b4593/html5/thumbnails/9.jpg)
Experience by Sponsor’s Origin (#of trials over the last 5 years)
9
ASIA 1%
GERMANY2%
NORWAY/SWEDEN/DENMARK3%
UNITED KINGDOM
7%
CANADA9%
SWITZERLAND11%
BELGIUM / NETHERLANDS
15%
FRANCE21%
USA31%
![Page 10: IDDI Presentation](https://reader035.vdocument.in/reader035/viewer/2022062406/55be32c8bb61eb59658b4593/html5/thumbnails/10.jpg)
Experience by Phase (#of trials over the last 5 years)
10
Multiple Phase11%
Phase I13%
Phase I/II2%
Phase II27%
Phase II/III3%
Phase III36%
Phase IV8%
![Page 11: IDDI Presentation](https://reader035.vdocument.in/reader035/viewer/2022062406/55be32c8bb61eb59658b4593/html5/thumbnails/11.jpg)
Experience by Therapeutic Area
(#of trials over the last 5 years)
11
Dermatology1%
Endocrine/Metabolic Diseases
1%
Musculoskeletal1%
Multiple 2% Gastroenterology
2%Immunology/
Vaccines2%
CNS 2%
Infectious Diseases4%
Cardio-vascular/ Cardiology
9%
Ophthalmology13%Oncology
63%
![Page 12: IDDI Presentation](https://reader035.vdocument.in/reader035/viewer/2022062406/55be32c8bb61eb59658b4593/html5/thumbnails/12.jpg)
Why IDDI?
![Page 13: IDDI Presentation](https://reader035.vdocument.in/reader035/viewer/2022062406/55be32c8bb61eb59658b4593/html5/thumbnails/13.jpg)
IDDI's Added Value
Team of talented professionals with extensive scientific depthDedicated staff with virtually no turnoverRobust, flexible, cost-effective EDC and IWR solutions20 years in the clinical research businessRecognized expertise in oncologyTrack record of success stories Extensive regulatory experience with involvement in 15 FDA/EMA approvalsWorldwide reputation and scientific visibilityIndependent status
13